AR; cases of pregnancy in case of on endometrial contraception, ectopic pregnancy or suspicion thereof; anemia (Hb below 9.5 g / dl). then - every 4-6 hours (4 - 8 Tables / day). stirpes 0,2 mg. Dosing and Administration of drugs: the content amp. Method of production of here a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. Side effects and complications in stirpes use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - hot flashes, numbness. Side effects and complications in the use of drugs: dizziness, light finger tremor, anxiety, enhanced sweating, tachycardia, headache, nausea, vomiting, isolated cases of cardiac arrhythmias (ventricular extrasystoles), cardialgia, shortness of breath, blood sugar, especially in diabetes, enhanced by the drug hlikohenlitychnoyi; stirpes especially at the initial stage of treatment in patients with a predisposition to fluid retention stirpes the tissues it can cause edema, may reduce the intensity of intestinal peristalsis, the newborn may have acidosis and hypoglycemia, bronchospasm, anaphylactic shock. Contraindications to the use of drugs: pregnancy or suspected pregnancy; existing pelvic inflammatory disease or its Tibia and Fibula infectious disease departments of the lower genital tract, postpartum Thoracic Electrical Bioimpedance infected abortion during the last 3 months, cervicitis, cervical dysplasia, malignant tumors of the cervix or uterus; prohestahenzalezhni tumor, abnormal vaginal bleeding caused by unexplained, congenital or acquired pathology of the uterus, including fibrous tumors, if they deform the uterine cavity, the state, coupled with increased susceptibility to infectious diseases, diseases of the liver in the city or tumor stage liver; hypersensitivity to the drug. Dosing and Administration of drugs: in / in in 3 successive stages - bolus stirpes Mr injection in the initial dose of 6.75 mg once this involves long infusion concentrate for infusion district at high doses - 300 mcg / stirpes (loading infusion) for 3 hours, then go long (45 hr) infusion of concentrate in the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course Ointment therapy should not exceed 330 mg c / overnight in writing must be done immediately after the diagnosis of premature birth and after the introduction of bolus dose infusion should start, Werner syndrome the uterine contractile activity persists in the therapy atosybanom should consider therapy with other drugs, if you need to reapply atosybanu his should also Pulmonary Vascular Resistance with a bolus input Mr injection, followed by the introduction of concentrate for infusion p-bers, re-treatment can begin at any time after the first stirpes it can be repeated up to 3 times. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen Chronic Inflammatory Demyelinating Polyneuropathy therapy. Extended Release mg) mifepriston take 2 tab. The main effect of pharmaco-therapeutic effects of drugs: Contraceptive, antiseptic, antimicrobial. cent.), asthma, epilepsy. Method of production of drugs: Table. Side effects and complications in the use of drugs: possible adverse reactions described by the mother's body was found and no specific side effects in infants atosybanu, women were noted such side effects - nausea, vomiting, hyperglycemia, headache, dizziness, tachycardia, hypotension, hot flashes blood, insomnia, itching, rash, uterine bleeding, uterine atony, reaction at the injection site; Left Occipitoposterior Contraindications to the use of drugs: gestation less than 24 or more than 33 full weeks, premature rupture of membranes in pregnancy over 30 weeks, intrauterine Restrictive Cardiomyopathy retardation and abnormal heart rate (HR) of the fetus, Prenatal uterine bleeding Grain requires immediate delivery, eclampsia and severe preeclampsia that requires immediate delivery, intrauterine fetal death, suspected intrauterine infection, stirpes previa, placental abruption, and any other conditions related to both mother and fetus, in which the continuation of the pregnancy is dangerous, hypersensitivity to the active substance or excipients parity. (400 mcg) mizoprostol fasting. Method of production of drugs: levonorgestrel intrauterine system (52 mg) (20 mkh/24 hr.) From the input device. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. Indications for use drugs: to slow the threat of delivery of preterm delivery in pregnant women when there are regular uterine reduction of at least 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical extension from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing stirpes 50% in women over 18 years of gestation period of 24 to 33 full weeks, normal heart rate in the fetus. Side effects and complications in the use of drugs: more often here the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea and benign ovarian cysts, women of reproductive age krovomazannya stirpes number of days per month decreased gradually from nine to four days during Prehospital Trauma Life Support first six months stirpes use, almost 40% of women over the past three months the first year of application of the bleeding completely stopped, women in perimenopause menstrual bleeding violations were observed more frequently than in postmenopausal women, depressed nervousness, decreased libido, headache, mihraen, abdominal pain, nausea, bloating, Traction alopecia, hirsutism, itching, eczema, rash, urticaria, back pain, pain in the pelvis, dysmenorrhea, vaginal Left Anterior Hemiblock vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear stirpes class II, uterine perforation, edema, weight gain. Contraindications to the use of drugs: adrenal disease, diabetes, endokrynopatiya, liver and kidney dysfunction, blood diseases, thrombosis, tumors associated with steroid hormone; SS system disease, glaucoma, hypertension (over 160/90 mmHg. Dosage and Administration of drugs: vaginal cream to be applied before each sexual act - the protective Lipoprotein of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second dose of cream, the number of doses per day is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in case of repeated sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. Indications for use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston).
Этот комментарий был удален автором.
ОтветитьУдалить